Acumen Showcases Advances in Alzheimer’s Research at Global

Acumen Showcases Advances in Alzheimer’s Research at Global

By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in Copenhagen. The company will include one oral session and two posters highlighting advances...

a.k.a. Brands Q4 Sales & EBITDA Rise, Gives 2026 Guidance

a.k.a. Brands Q4 Sales & EBITDA Rise, Gives 2026 Guidance

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said fourth quarter net sales increased 3.1% from a year earlier to $164 million. U.S. net sales grew 5.3%, while adjusted EBITDA was $2.5 million, or 1.5% of net sales, compared...

On Holding Q4 Net Sales Jump, Gives 2026 Guidance

On Holding Q4 Net Sales Jump, Gives 2026 Guidance

By Karen Roman On Holding AG (NYSE: ONON) said net sales were up 22.6% to CHF 743.8 million in the fourth quarter compared to the year prior. DTC net sales increased 21.7% to CHF 360.6 million in the quarter, while...

Input your search keywords and press Enter.